Hua Gong, M.D., Ph.D. , appointed Chief Operating Officer and Head of Precision Medicine JC Xu, M.D., Ph.D., appointed Chief Scientific Officer Qinghai Zhao, Ph.D.,  appointed Chief Manufacturing Officer Company establishes presence in San Diego as  a  C enter of  E xcellence  for  P recision  M ... read more »

Tanabe Research Labs and Adagene to develop a first-in-class therapeutic with a next-generation masked antibody drug conjugate (ADC), incorporating Adagene's SAFEbody™ technology platform SAN FRANCISCO, and SUZHOU, China, and SAN DIEGO, June 10, 2020 /PRNewswire/ -- Adagene Incorporated, a ... read more »

San Francisco, California. and Suzhou, China, May 29, 2020 — Adagene, Inc. a platform-driven, clinical-stage company, today announced that positive results of its novel anti-CD137 agonist, ADG106, from the Phase I trial in China will be presented in a poster at the 2020 American Society of Clinical ... read more »

SAN FRANCISCO and SUZHOU, China, Jan. 09, 2020 (GLOBE NEWSWIRE) -- Adagene, Inc., a clinical-stage, leading-edge oncology immunotherapy company driven by a powerful antibody discovery and engineering platform, today announced that Peter Luo, Ph.D., Co-founder and Chief Executive Officer, will ... read more »

Proceeds will support advancement of lead immunotherapy clinical programs and extend the frontiers of novel technology SAN FRANCISCO and SUZHOU, China, Jan. 08, 2020 (GLOBE NEWSWIRE) -- Adagene, Inc., a clinical-stage, leading-edge oncology immunotherapy company driven by a powerful antibody ... read more »